Published in Blood Weekly, March 9th, 1998
That's the finding of a nationwide Creutzfeldt-Jakob Disease (CJD) investigational lookback study, now in its third year, reported Dr. Marian T. Sullivan, Executive Director, National Blood Data Resource Center, Bethesda, Maryland.
Sullivan described the CJD study, performed with researchers from the American Red Cross Blood Services, the New York Blood Center, and the U.S. Centers for Disease Control and Prevention (CDC) at the fourth annual Blood Safety & Screening Conference, sponsored by Cambridge Healthtech Institute, held...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.